Dysfunctional sensory gating in anxiety disorders, indexed by the failure to inhibit the P50 event-related potential (ERP) to repeated stimuli, has been linked to deficits in the major inhibitory neurotransmitter γ-aminobutyric acid (GABA).
Aims/Methods:
This study, conducted in 30 healthy volunteers, examined the acute effects of GABAA (lorazepam: 1 mg) and GABAB receptor (baclofen: 10 mg) agonists on P50 measures of auditory sensory gating within a paired-stimulus (S1-S2) paradigm and assessed changes in gating in relation to self-ratings of anxiety.
Results:
Compared to placebo, lorazepam reduced ERP indices of sensory gating by attenuating response to S1. Although not directly impacting P50 inhibition, baclofen-induced changes in gating (relative to placebo) were negatively correlated with trait but not state anxiety.
Conclusions:
These preliminary findings support the involvement of GABA in sensory gating and tentatively suggest a role for GABAB receptor signaling in anxiety-associated gating dysregulation.
AtackJR (2010) Development of subtype-selective GABAA receptor compounds for the treatment of anxiety, sleep disorders and epilepsy. In: MontiJPandi-PerumalSRatnasS, et al. (eds) GABA and Sleep: Molecular, Functional and Clinical Aspects. Switzerland: Springer Basel, pp. 25–72.
2.
BakNRostrupELarssonHBW, et al. (2014) Concurrent functional magnetic resonance imaging and electroencephalography assessment of sensory gating in schizophrenia. Hum Brain Mapp35: 3578–3587.
3.
BastenVStelzelCFiebachC (2011) Trait anxiety modulates the neural efficiency of inhibitory controle. J Cogn Neurosci23: 3132–3145.
4.
Bergado-AcostaJRMüllerIRichter-LevinG, et al. (2014) The GABA-synthetic enzyme GAD65 controls circadian activation of conditioned fear pathways. Behav Brain Res260: 92–100.
5.
Bickford-WimerPCNagamotoHJohnsonR, et al. (1990) Auditory sensory gating in hippocampal neurons: A model system in the rat. Biol Psychiatry27: 183–192.
6.
BoutrosNNKorzyukovOJansenB, et al. (2004) Sensory gating deficits during the mid-latency phase of information processing in medicated schizophrenia patients. Psychiatry Res126: 203–215.
7.
BremnerJDInnisRBSouthwickSM, et al. (2000) Decreased benzodiazepine receptor binding in prefrontal cortex in combat-related posttraumatic stress disorder. Am J Psychiatry157: 1120–1126.
CastanedaAETuulio-HenrikssonAMarttunenM, et al. (2008) A review on cognitive impairments in depressive and anxiety disorders with a focus on young adults. J Affect Disord106: 1–27.
10.
ChangWPArfkenCLSangalMP, et al. (2011) Probing the relative contribution of the first and second responses to sensory gating indices: A meta-analysis. Psychophysiology48: 980–992.
11.
ChenXvan GervenJCohenA, et al. (2019) Human pharmacology of positive GABA-A subtype-selective receptor modulators for the treatment of anxiety. Acta Pharmacol Sin40: 571–582.
12.
ClementzBA (1998) Psychophysiological measures of (dis)inhibition as liability indicators for schizophrenia. Psychophysiology35: 648–668.
13.
CoonHPlaetkeRHolikJ, et al. (1993) Use of a neurophysiological trait in linkage analysis of schizophrenia. Biol Psychiatry34: 277–289.
14.
CryanJFKaupmannK (2005) Don’t worry ‘B’ happy!: A role for GABA B receptors in anxiety and depression. Trends Pharmacol Sci26: 36–43.
15.
DumanRSSanacoraGKrystalJH (2019) Altered connectivity in depression: GABA and glutamate neurotransmitter deficits and reversal by novel treatments. Neuron102: 75–90.
16.
ElgarfAASiebertDCBSteudleF, et al. (2018) Different benzodiazepines bind with distinct binding modes to GABA A receptors. ACS Chem Biol13: 2033–2039.
17.
EndlerNKocovskiN (2001) State and trait anxiety revisited. J Anx Disorders15: 231–245.
18.
FergusonBRGaoWJ (2018) Thalamic control of cognition and social behavior via regulation of gamma-aminobutyric acidergic signaling and excitation/inhibition balance in the medial prefrontal cortex. Biol Psychiatry83: 657–669.
19.
FirstMBSpitzerRLGibbonM, et al. (2002) Structure clinical interview for DSM-IV-TR axis I disorders-non-patient edition (SCID-I/NP, 11/2002 revision). New York, NY: Biometric Research Department, New York State Psychiatric Institute.
20.
FogaçaMVDumanRS (2019) Cortical GABAergic dysfunction in stress and depression: New insights for therapeutic interventions. Front Cell Neurosci13: 1–20.
21.
FreedmanRAdlerLEMyles-WorsleyM, et al. (1996) Inhibitory gating of an evoked response to repeated auditory stimuli in schizophrenic and normal subjects: Human recordings, computer simulation, and an animal model. Arch Gen Psychiatry53: 1114–1121.
22.
FuerstDRGallinatJBoutrosNN (2007) Range of sensory gating values and test/retest reliability in normal subjects. Psychophysiology44: 620–626.
23.
GhisolfiESHeldtEZanardoAP, et al. (2006) P50 sensory gating in panic disorder. J Psychiatr Res40: 535–540.
24.
GhisolfiESMargisRBeckerJ, et al. (2004) Impaired P50 sensory gating in post-traumatic stress disorder secondary to urban violence. Int J Psychophysiol51: 209–214.
25.
GjiniKBoutrosNNHaddadL, et al. (2013) Evoked potential correlates of Post-Traumatic Stress Disorder in refugees with history of exposure to torture. J Psychiatr Res47: 1492–1498.
26.
GrattonGColesMGHHDonchinE (1983) A new method for off-line removal of ocular artifact. Electroencephalogr Clin Neurophysiol55: 468–484.
27.
GreenSAHernandezLBookheimerSY, et al. (2017) Reduced modulation of thalamocortical connectivity during exposure to sensory stimuli in ASD. Autism Res10: 801–809.
28.
HashimotoTShimizuEKoikeK, et al. (2008) Deficits in auditory P50 inhibition in obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry32: 288–296.
29.
HaslerGNugentACCarlsonPJ, et al. (2008) Altered cerebral γ-aminobutyric acid type a-benzodiazepine receptor binding in panic disorder determined by [11C]flumazenil positron emission tomography. Arch Gen Psychiatry65: 1166–1175.
30.
HeldtSAMouLResslerKJ (2012) In vivo knockdown of GAD67 in the amygdala disrupts fear extinction and the anxiolytic-like effect of diazepam in mice. Transl Psychiatry2: e181-e181.
31.
HershmanKFreedmanRBickfordP (1995) GABA B antagonists diminish the inhibitory gating of auditory response in the rat hippocampus. Neurosci Lett190: 133–136
32.
HolsteinDHVollenweiderFXJänckeL, et al. (2010) P50 suppression, prepulse inhibition, and startle reactivity in the same patient cohort suffering from posttraumatic stress disorder. J Affect Disord126: 188–197.
33.
HuYDolcosS (2017) Trait anxiety mediates the link between inferior frontal cortex volume and negative affective bias in healthy adults. Soc Cogn Affect Neurosciences12: 775–782.
34.
HunterMVillarrealGMcHaffieGR, et al. (2011) Lateralized abnormalities in auditory M50 sensory gating and cortical thickness of the superior temporal gyrus in post-traumatic stress disorder: Preliminary results. Psychiatry Res Neuroimaging191: 138–144.
35.
IsaacsonJSolisJNicollR (1993) Local and diffuse synaptic actions of GABA in the hippocampus. Neuron10: 165–175.
36.
JacobTCMossSJJurdR (2008) GABAA receptor trafficking and its role in the dynamic modulation of neuronal inhibition. Nat Rev Neurosci9: 331–343.
37.
JavanbakhtALiberzonIAmirsadriA, et al. (2011) Event-related potential studies of post-traumatic stress disorder: A critical review and synthesis. Biol Mood Anxiety Disord1: 1–12.
JurcakVTsuzukiDDanI (2007) 10/20, 10/10, and 10/5 systems revisited: Their validity as relative head-surface-based positioning systems. Neuroimage34: 1600–1611.
40.
KarlAMaltaLSMaerckerA (2006) Meta-analytic review of event-related potential studies in post-traumatic stress disorder. Biol Psychol71: 123–147.
41.
KirouacGJ (2021) The paraventricular nucleus of the thalamus as an integrating and relay node in the brain anxiety network. Front Behav Neurosci15: 1–14.
42.
KniazeffJ (2020) The different aspects of the GABAB receptor allosteric modulation. Adv Pharmacol88: 83–113.
43.
KyriakopoulosAGreenblattDShaderR (1978) Clinical pharmacokinetics of lorazepam: A review. J Clin Psychiatry39: 16–23.
44.
LeeHKDunwiddieTVHofferBJ (1979) Interaction of diazepam with synaptic transmission in the in vitro rat hippocampus. Naunyn Schmiedebergs Arch Pharmacol309: 131–136.
45.
LiXKaczanowskaKFinnMG, et al. (2015) The GABAB receptor positive modulator BHF177 attenuated anxiety, but not conditioned fear, in rats. Neuropharmacology97: 357–364.
46.
LuJLobarinasEDengA, et al. (2011) GABAergic neural activity involved in salicylate-induced auditory cortex gain enhancement. Neuroscience189: 187–198.
47.
LydiardRB (2003) The role of GABA in anxiety disorders. J Clin Psychiatry64: 21–27.
48.
MaJLeungLS (2011) GABA(B) receptor blockade in the hippocampus affects sensory and sensorimotor gating in Long-Evans rats. Psychopharmacology (Berl)217: 167–76.
49.
MaliziaALCunninghamVJBellCJ (1998) Decreased brain GABAA-benzodiazepine receptor binding in panic disorder: Preliminary results from a quantitative PET study. Arch Gen Psychiatry55: 715–720.
50.
MartinMR (1982) Baclofen and the brain stem auditory evoked potential. Exp Neurol76: 675–680.
51.
MaxwellM (1992) Family Interview for Genetic Studies (FIGS): Manual for FIGS. Clinical Neurogenetics Branch, Intramural Research Program. Bethesda, MD: National Institute of Mental Health.
52.
MayerARHanlonFMFrancoAR, et al. (2009) The neural networks underlying auditory sensory gating. Neuroimage44: 182–189.
53.
MeteranHVindbjergEUldallSW, et al. (2019) Startle habituation, sensory, and sensorimotor gating in trauma-affected refugees with posttraumatic stress disorder. Psychol Med49: 581–589.
54.
MillerCFreedmanR (1995) The activity of hippocampal interneurons and pyramidal cells during the response of the hippocampus to repeated auditory stimuli. Neuroscience69: 371–381.
55.
NaharLCorderoRNuttO, et al. (2016) Validated method for the quantification of baclofen in human plasma using solid-phase extraction and liquid chromatography – tandem mass spectrometry. J Anal Toxicol40: 112–123.
56.
NikolausSHautzelHMüllerH-W (2014) Focus on GABAA receptor function: A comparative analysis of in vivo imaging studies. Nuklearmedizin-Nucl Med53: 227–337.
57.
NobreMCabralABrandaoM (2010) Gabaergic regulation of auditory sensory gating in low- and high-anxiety rats submitted to a fear conditioning paradigm. Neurosci171: 1152–1163.
58.
NussP (2015) Anxiety disorders and GABA neurotransmission: A disturbance of modulation. Neuropsychiatr Dis Treat11: 165–175.
59.
NuttDJMaliziaAL (2004) Structural and functional brain changes in posttraumatic stress disorder. J Clin Psychiatry65: 11–17.
60.
OlpeHRSteinmannMWFerratT, et al. (1993) The actions of orally active GABAB receptor antagonists on GABAergic transmission in vivo and in vitro. Eur J Pharmacol233: 179–186.
61.
PizzoRO’LearyOFCryanJF (2018) Elucidation of the neural circuits activated by a GABAB receptor positive modulator: Relevance to anxiety. Neuropharmacology136: 129–145.
62.
PrévotTSibilleE (2021) Altered GABA-mediated information processing and cognitive dysfunctions in depression and other brain disorders. Mol Psychiatry26: 151–167.
63.
SaviolaFPappaianniEMontiA, et al. (2020) Trait and state anxiety are mapped differently in the human brain. Sci Rep20: 11112.
64.
SherringtonSC (1948) The integrative action of the nervous system, vol. 107. New Haven, CT: Yale University Press, pp. 606–606.
65.
SigelE PLuscherB (2012) A closer look at the high affinity benzodiazepine binding site on GABAA receptors. Curr Top Med Chem11: 241–246.
66.
SmithDABoutrosNNSchwarzkopfSB (1994) Reliability of P50 auditory event-related potential indices of sensory gating. Psychophysiology31: 495–502.
67.
SpielbergerCDGonzalez-ReigosaFMartinez-UrrutiaA, et al. (1971) The state-trait anxiety inventory. Revista Interamericana de Psicología/Int J Psychol5: 3–4.
68.
SunHMaCLKellyJB, et al. (2006) GABAB receptor-mediated presynaptic inhibition of glutamatergic transmission in the inferior colliculus. Neurosci Lett399: 151–156.
69.
SzczepaniakWSMøllerAR (1996) Effects of (−)-baclofen, clonazepam, and diazepam on tone exposure-induced hyperexcitability of the inferior colliculus in the rat: Possible therapeutic implications for pharmacological management of tinnitus and hyperacusis. Hear Res97: 46–53.
70.
TsaiM-LCrutchleyMBoyceR, et al. (2012) Long-lasting gating deficit accompanied by GABA(B) receptor dysfunction in the hippocampus after early-life limbic seizures in rats. Physiol Behav106: 534–546.
71.
Van LuijtelaarG (2003) The effects of diazepam on sensory gating in healthy volunteers. Neurosci Lett341: 65–68.
72.
VolelBAPetelinDSAkhapkinRV, et al. (2018) Cognitive impairment in anxiety disorders. Nevrologiya, Neiropsikhiatriya, Psikhosomatika10: 78–82.
73.
WaldmeierPCKaupmannKUrwylerS (2008) Roles of GABAB receptor subtypes in presynaptic auto- and heteroreceptor function regulating GABA and glutamate release. J Neural Transm115: 1401–1411.
74.
WoodETCummingsKKJungJ, et al. (2021) Sensory over-responsivity is related to GABAergic inhibition in thalamocortical circuits. Transl Psychiatry11: 39.
